Basic information
- Name:
Capsaicin
- CAS No.:
404-86-4
- Molecular Structure:

- Formula:
- C18H27NO3
- Molecular Weight:
- 305.42
- Deleted CAS:
- 912457-62-6
- Synonyms:
- Styptysat;6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI);8-Methyl-N-vanillyl-6-nonenamide, (E)-;6-Nonenamide, N-[ (4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)-;trans-8-Methyl-N-vanillyl-6-nonenamide;6-Nonenamide,N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl-,(6E)-;Capsaicin (JAN/USP);N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide;(E)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide;(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide;Zostrix;Capsaicin [USAN];6-Nonenamide, 8-methyl-N-vanillyl-, (E)-;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (6E)-;Prestwick_204;Capsaicin [in oleoresin of capsicum];EPA Pesticide Chemical Code 070701;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-;FEMA No. 3404;Zostrix (TN);Ratden PE 40;N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide, (E)-;N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide;(E)-8-Methyl-N-vanillyl-6-nonenamide;
- EINECS:
- 206-969-8
- Density:
- 1.041 g/cm3
- Melting Point:
- 62-65 °C(lit.)
- Boiling Point:
- 511.5 °C at 760 mmHg
- Flash Point:
- 263.1 °C
- Solubility:
- insoluble in water
- Appearance:
- Off-white crystalline solid
- Hazard Symbols:
T,
T+- Risk Codes:
- 25-37/38-41-42/43-36/37/38
- Safety Description:
- 22-26-28-36/39-45-36/37/39 Details
- Transport Information:
- UN 2811 6.1/PG 2
- particular:
- particular
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
Molecular Structure:
.png)
Molecular Formula: C18H27NO3
Molecular Weight: 305.4119
IUPAC Name: (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
Synonyms of Capsaicin (CAS NO.404-86-4): (E)-8-Methyl-N-vanillyl-6-nonenamide ; (E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide ; 4-13-00-02588 (Beilstein Handbook Reference) ; 6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl ; 6-Nonenamide, 8-methyl-N-vanillyl-, (E)- ; 6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)- ; 8-Methyl-N-vanillyl-6-nonenamide, (E)- ; BRN 2816484 ; CCRIS 1588 ; Capsaicine ; Caswell No. 158 ; EINECS 206-969-8 ; EPA Pesticide Chemical Code 070701 ; FEMA No. 3404 ; HSDB 954 ; Isodecenoic acid vanillylamide ; N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide, (E)- ; N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide ; NCI-C56564 ; NSC 56353 ; Qutenza ; Styptysat ; UNII-S07O44R1ZM ; trans-8-Methyl-N-vanillyl-6-nonenamide
CAS NO: 404-86-4
Classification Code: Analgesic [topical] ; Antineuralgic, specific pain syndromes, topical ; Antipruritics ; Dermatologic Agents ; Mutation data ; Natural Product ; Peripheral Nervous System Agents ; Sensory System Agents ; Tumor data
Melting point: 62-65 °C
Index of Refraction: 1.523
Molar Refractivity: 89.69 cm3
Molar Volume: 293.1 cm3
Surface Tension: 38.7 dyne/cm
Density: 1.041 g/cm3
Flash Point: 263.1 °C
Enthalpy of Vaporization: 81.2 kJ/mol
Boiling Point: 511.5 °C at 760 mmHg
Vapour Pressure: 4.41E-11 mmHg at 25°C
History
The molecule of capsaicin was first isolated in crystalline form in 1816 by P. A. Bucholz and again 30 years later by L.T. Thresh, who gave it the name "capsaicin". In 1878, the Hungarian doctor Endre Hogyes isolated it and proved that it not only caused the burning feeling when in contact with mucous membranes but also increased secretion of gastric juice. Capsaicin was first synthesized in 1930 by E. Spath and S. F. Darling.
Uses
Capsaicin (CAS NO.404-86-4) is used as a tool in neurobiological research. Prototype vanilloid receptor agonist. Topical analgesic.
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LDLo | intravenous | 1600ug/kg (1.6mg/kg) | FAO Nutrition Meetings Report Series. Vol. 48A, Pg. 60, 1970. | |
| guinea pig | LD50 | intraperitoneal | 1100ug/kg (1.1mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: EXCITEMENT | Toxicon. Vol. 18, Pg. 215, 1980. |
| hamster | LD50 | intraperitoneal | > 120mg/kg (120mg/kg) | Toxicon. Vol. 18, Pg. 215, 1980. | |
| mouse | LD50 | intramuscular | 7800ug/kg (7.8mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Toxicon. Vol. 18, Pg. 215, 1980. |
| mouse | LD50 | intraperitoneal | 6500ug/kg (6.5mg/kg) | BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Toxicon. Vol. 18, Pg. 215, 1980. |
| mouse | LD50 | intratracheal | 1600ug/kg (1.6mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Toxicon. Vol. 18, Pg. 215, 1980. |
| mouse | LD50 | intravenous | 400ug/kg (0.4mg/kg) | Yakhak Hoe Chi. Journal of the Pharmaceutical Society. Vol. 25(3), Pg. 101, 1981. | |
| mouse | LD50 | oral | 47200ug/kg (47.2mg/kg) | Yakhak Hoe Chi. Journal of the Pharmaceutical Society. Vol. 25(3), Pg. 101, 1981. | |
| mouse | LD50 | rectal | > 218mg/kg (218mg/kg) | Toxicon. Vol. 18, Pg. 215, 1980. | |
| mouse | LD50 | skin | > 512mg/kg (512mg/kg) | Toxicon. Vol. 18, Pg. 215, 1980. | |
| mouse | LD50 | subcutaneous | 9000ug/kg (9mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: EXCITEMENT | Toxicon. Vol. 18, Pg. 215, 1980. |
| rabbit | LD50 | intraperitoneal | > 50mg/kg (50mg/kg) | Toxicon. Vol. 18, Pg. 215, 1980. | |
| rat | LD50 | intraperitoneal | 9500ug/kg (9.5mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Toxicon. Vol. 18, Pg. 215, 1980. |
Safety Profile
Hazard Codes of Capsaicin (CAS NO.404-86-4):
T,
T+
Risk Statements: 25-41-42/43-36/37/38
R25: Toxic if swallowed.
R41: Risk of serious damage to the eyes.
R42/43: May cause sensitization by inhalation and skin contact.
R36/37/38: Irritating to eyes, respiratory system and skin.
Safety Statements: 22-26-28-45-36/37/39
S22: Do not breathe dust.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S28: After contact with skin, wash immediately with plenty of soap-suds.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
RIDADR: UN 2811 6.1/PG 2
WGK Germany: 3
RTECS: RA8530000
F: 10-21
HazardClass: 6.1(a)
PackingGroup: II

